[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2122564T3 - Derivados de bifenilo como antagonistas del receptor 5ht1d. - Google Patents

Derivados de bifenilo como antagonistas del receptor 5ht1d.

Info

Publication number
ES2122564T3
ES2122564T3 ES95911321T ES95911321T ES2122564T3 ES 2122564 T3 ES2122564 T3 ES 2122564T3 ES 95911321 T ES95911321 T ES 95911321T ES 95911321 T ES95911321 T ES 95911321T ES 2122564 T3 ES2122564 T3 ES 2122564T3
Authority
ES
Spain
Prior art keywords
6alkyl
6alkoxy
independently hydrogen
conr
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95911321T
Other languages
English (en)
Inventor
Laramie Mary Gaster
Paul Adrian Wyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406041A external-priority patent/GB9406041D0/en
Priority claimed from GB9406040A external-priority patent/GB9406040D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2122564T3 publication Critical patent/ES2122564T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE PRESENTAN COMPONENTES DE FORMULA (I), PROCESOS PARA SU PREPARACION Y SU USO, COMO AGENTES CNS, EN LOS QUE R{SUP,1} ES HIDROGENO, HALOGENO, C{SUB,1-6}ALQUILO, C{SUB,3-6}CICLOALQUILO, COC{SUB,1-6}ALQUILO, C{SUB,1-6} ALCOXI, HIDROXI, HIDROXIC{SUB,16}ALQUILO, HIDROXIC{SUB,1-6}ALCOXI, C{SUB,1-6}ALCOXI C{SUB,16}ALCOXI, ACILO, NITRO, TRIFLUOROMETILO CIANO, SR{SUP,9}, SOR{SUP,9}, SO{SUB,2}R{SUP,9}, SO{SUB,2}NR{SUP,10}R{SUP,11}, CO{SUB,2}R{SUP,10}, CONR{SUP,10}R{SUP,11}, CO{SUB,2}NR{SUP,10}R{SUP,11}, CONR{SUP,10}(CH{SUB,2}){SUB,P}CO{SUB,2}R{SUP,11}, (CH{SUB,2}){SUB,P}NR{SUP,10}R{SUP,11}, (CH{SUB,2}){SUB,P}CONR{SUP,10}R{SUP,11}, (CH{SUB,2}){SUB,P}CO{SUB,2}C{SUB,1-6}ALQUILO, NR{SUP,10}R{SUP,11}, NR{SUP,10}CO{SUB,2}R{SUP,11}, NR{SUP,10}CONR{SUP,10}R{SUP,11}, CR{SUP,10}=NOR{SUP,11}, CNR{SUP,10}=NOR{SUP,11}, DONDE R{SUP,10} Y R{SUP,11} SON INDEPENDIENTEMENTE HIDROGENO O C{SUB,1-6}ALQUILO Y P ES 1 HASTA 3, R{SUP,2} Y R{SUP,3} SON INDEPENDIENTEMENTE HIDROGENO, HALOGENO, C{SUB,1-6}ALQUILO, C{SUB,3-6}CICLOALQUILO, C{SUB,36}CICLOALQUENILO, C{SUB,1-6}ALCOXI, ACILO, ARILO, ACILOXI, HIDROXI, NITRO, TRIFLUOROMETILO, CIANO, CO{SUB,2}R{SUP,10}, CONR{SUP,10}R{SUP,11}, NR{SUP,10}R{SUP,11} DONDE R{SUP,10} Y R{SUP,11} SON INDEPENDIENTEMENTE HIDROGENO O C{SUB,1-6}ALQUILO, R{SUP,4} Y R{SUP,5} SON INDEPENDIENTEMENTE HIDROGENO O C{SUB,16}ALQUILO, R{SUP,6} ES HIDROGENO, HALOGENO, HIDROXI, C{SUB,16}ALQUILO O C{SUB,1-6}ALCOXI, R{SUP,7} Y R{SUP,8} SON INDEPENDIENTEMENTE HIDROGENO, C{SUB,1-6}ALQUILO, ARALQUILO, O JUNTO CON EL ATOMO DE NITROGENO AL QUE ESTAN UNIDOS, FORMAN UN ANILLO HETEROCICLICO DE 5-7 MIEMBROS SUSTITUIDO OPCIONALMENTE QUE CONTIENE UNO O DOS HETEROATOMOS SELECCIONADOS ENTRE OXIGENO, NITROGENO O AZUFRE, A ES CONH O NHCO; B ES OXIGENO, S(O){SUB,P} DONDE P ES 0, 1 O 2, O B ES NR{SUP,12} DONDE R{SUP,12} ES HIDROGENO O C{SUB,1-6}ALQUILO, M ES 2 Y 4; Y N ES 1 O 2.
ES95911321T 1994-03-26 1995-03-09 Derivados de bifenilo como antagonistas del receptor 5ht1d. Expired - Lifetime ES2122564T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9406041A GB9406041D0 (en) 1994-03-26 1994-03-26 Novel compounds
GB9406040A GB9406040D0 (en) 1994-03-26 1994-03-26 Novel compounds

Publications (1)

Publication Number Publication Date
ES2122564T3 true ES2122564T3 (es) 1998-12-16

Family

ID=26304590

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95911321T Expired - Lifetime ES2122564T3 (es) 1994-03-26 1995-03-09 Derivados de bifenilo como antagonistas del receptor 5ht1d.

Country Status (6)

Country Link
EP (1) EP0752982B1 (es)
JP (1) JPH09510718A (es)
AT (1) ATE172187T1 (es)
DE (1) DE69505362T2 (es)
ES (1) ES2122564T3 (es)
WO (1) WO1995026328A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
FR2737721B1 (fr) * 1995-08-08 1997-09-05 Roussel Uclaf Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant
GB9707830D0 (en) * 1997-04-18 1997-06-04 Smithkline Beecham Plc Novel compounds
US20020049211A1 (en) * 2000-09-06 2002-04-25 Sobolov-Jaynes Susan Beth Combination treatment for depression and anxiety
WO2004010943A2 (en) * 2002-07-31 2004-02-05 Smithkline Beecham Corporation Substituted benzanilides as modulators of the ccr5 receptor
EP1720826A4 (en) * 2004-03-02 2007-10-31 Neurogen Corp HETEROALKYL SUBSTITUTED BIPHENYL-4-CARBOXYL ACRYLAMIDE ANALOG
WO2008154484A1 (en) 2007-06-08 2008-12-18 Mannkind Corporation Ire-1a inhibitors
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3756E (es) * 1975-08-20 1981-06-22 Chugai Pharmaceutical Co Ltd Procedimiento para producir derivados de benzanilida
US4038416A (en) * 1975-09-11 1977-07-26 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition and method of the use thereof
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
GB2276161A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benzanilide derivatives

Also Published As

Publication number Publication date
EP0752982B1 (en) 1998-10-14
WO1995026328A1 (en) 1995-10-05
JPH09510718A (ja) 1997-10-28
ATE172187T1 (de) 1998-10-15
DE69505362T2 (de) 1999-04-29
EP0752982A1 (en) 1997-01-15
DE69505362D1 (de) 1998-11-19

Similar Documents

Publication Publication Date Title
ATE180468T1 (de) Anthranilsäure derivate
ATE151758T1 (de) 4-benzoyl-isoxazol derivate, deren herstellung und deren verwendung als herbizide
ATE448226T1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
ES8802517A1 (es) Un procedimiento para preparar fenoxialquil (substituido con heterocido)-isoxazoles y furanos.
ES492116A0 (es) Un procedimiento para la preparacion de imidazol-cianoguani-dinas.
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
ES2122564T3 (es) Derivados de bifenilo como antagonistas del receptor 5ht1d.
ATE182889T1 (de) Bicyclische amidinderivate als no-synthetase inhibitoren
EE200000059A (et) Tetrahüdro-gamma-karboliinid
SE8406302D0 (sv) New aminoguanidine derivatives and a process for the preparation thereof
ES525484A0 (es) Un procedimiento para obtener derivados de indanilbenzamida
ES515904A0 (es) "procedimiento para preparar nuevas triazoloquinazolonas".
WO2000005224A3 (en) Heterocyclic derivatives and their use as integrin inhibitor
SE8501988L (sv) Iminotiazolidinderivat
ES506103A0 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas
ES8301480A1 (es) Un procedimiento para la produccion de derivados de 11-piperazinil-5h--pirrolo 1,2-b, 1,2,5 benzotriazepina.
ES514628A0 (es) "procedimiento para la preparacion de heteroariloxipropanolaminas".
ES8403130A1 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES497664A0 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas -(2) sustituidas
NO20006065D0 (no) Cyanoiminokinoksalinderivater
IL63649A0 (en) Urea derivatives,their preparation and their use as fungicides
ES2087325T3 (es) Derivados de 1,2,4-triazolo(1,5-a)pirimidina, procedimiento para su preparacion, medicamentos que los contienen y su utilizacion.
ATE164069T1 (de) Verwendung von 5-thia-1,4-diazabicyclo (4.2.0> octane-3,8-dioxo verbindungen in der antitumor- therapie
AR013306A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlos, las composiciones herbicidas que los contienen y el procedimiento de aplicacion dedichos compuestos.
GB1488465A (en) Urea derivatives and their use as herbicides

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 752982

Country of ref document: ES